Parkinson's Disease: Treatment
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Dosage Regimen: Fixed Dose
Parkinson's Disease: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 19, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Alexandra McGuckin1, Yu-Yan Poon1, Galit Kleiner2,3
1Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
No abstract available in PubMed .
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020